Hillstream BioPharma Inc.

NASDAQ: HILS · Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM

Hillstream BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
10.94M 6.51M 4.36K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
11.04K 178.09K 617.32K
Total Current Assets
10.95M 6.69M 621.68K
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a
Total Assets
10.95M 6.69M 621.68K
Account Payables
908.58K 954.5K 1.46M
Deferred Revenue
n/a n/a 697.84K
Short-Term Debt
n/a n/a 1.39M
Other Current Liabilities
906.47K 190.47K 1.68M
Total Current Liabilities
1.82M 1.14M 4.53M
Long-Term Debt
n/a n/a 772.9K
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
n/a 954.5K 772.9K
Total Liabilities
1.82M 1.14M 5.31M
Total Debt
n/a n/a 2.17M
Common Stock
1.18K 1.16K 636.00
Retained Earnings
-24.7M -15.38M -6.91M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
9.13M 5.54M -4.68M
Total Investments
n/a n/a n/a